Modulation of Osteoblast-like Cell Behavior by Activation of Protease-Activated Receptor-1
- 1 August 1999
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 14 (8) , 1320-1329
- https://doi.org/10.1359/jbmr.1999.14.8.1320
Abstract
In addition to playing a central role in thrombosis and hemostasis, the serine protease thrombin is a specific agonist for a variety of functional responses in cells including osteoblast-like cells. Many of the cellular responses to thrombin are mediated by protease-activated receptor-1 (PAR-1). Since osteoblasts express PAR-1 in vivo during development, the effect of PAR-1 activation on proliferation and differentiation in primary rat osteoblast-like cells was investigated. Thrombin or the rat PAR-1-activating peptide SFFLRNPSENTFELVPL (SFFL) stimulated cell proliferation (as assessed by 3H- thymidine incorporation) of primary osteoblast-like cells derived from long bone or calvaria, and treatment with antibodies to PAR-1 abolished the proliferative response to thrombin. Activation of PAR-1 by thrombin or SFFL inhibited endogenous alkaline phosphatase (ALP) activity and caused a transient elevation of intracellular calcium in the osteoblast-like cells. Calcium mobilization was not, however, required for thrombin's effect on proliferation or ALP activity. The ability of a number of growth factors and hormones to regulate expression of PAR-1 in osteoblast-like cells was investigated. Expression of PAR-1 transcript and protein by osteoblast-like cells in vitro was markedly increased by treatment with transforming growth factor-beta (TGF-beta), and the proliferative response to thrombin was enhanced by TGF-beta pretreatment. Platelet-derived growth factor-BB caused a slight but significant down-regulation of PAR-1 mRNA expression. Thrombin caused a transient increase in PAR-1 expression, whereas neither parathyroid hormone-related peptide nor 1, 25-dihydroxyvitamin D3 had any effect. The observations described here suggest that PAR-1 mediates thrombin-induced osteoblast proliferation, which in turn may contribute to responses of osteoblasts to osteogenic growth factors.Keywords
This publication has 39 references indexed in Scilit:
- Expression of the Thrombin Receptor in Developing Bone and Associated TissuesJournal of Bone and Mineral Research, 1998
- Protease-activated receptor 3 is a second thrombin receptor in humansNature, 1997
- The Thrombin Receptor Is Present in Myoblasts and Its Expression Is Repressed upon FusionPublished by Elsevier ,1996
- Calvarial and limb bone cells in organ and monolayer culture do not show the same early responses to dynamic mechanical strainJournal of Bone and Mineral Research, 1995
- Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor.Journal of Clinical Investigation, 1993
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991
- Stimulation of bone formation in vivo by transforming growth factor-β: Remodeling of woven bone and lack of inhibition by indomethacinBone, 1990
- Thrombin's effects on osteoblastic cells I. Cytosolic calcium and phosphoinositidesBiochemical and Biophysical Research Communications, 1989
- Kinetics of the inhibition of thrombin by hirudinBiochemistry, 1986
- Thrombin, a stimulator of bone resorptionBioscience Reports, 1983